ArticleFrontiers in pharmacology2026

Roles of myeloperoxidase and the AMPK/PI3K/AKT/eNOS pathway in osimertinib-induced cardiotoxicity: multilevel evidence from disequilibrium analysis, network pharmacology, mendelian randomization, and animal experiments.

Jing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.